Key facts
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for Inventiva S.A. Ordinary shares, nominal value 0.01 Euro per share.
- Disclosed ownership: 3.5%.
- Date of event: 31 Dec 2025.
GREAT POINT PARTNERS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Inventiva S.A. Ordinary shares, nominal value 0.01 Euro per share
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Shares outstanding
- 194,363,009 shares
- Disclosed Ownership
- 6,783,269 shares
- Ownership
- 3.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:17:06 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Key filing fact
GREAT POINT PARTNERS LLC disclosed 3.5% ownership in Inventiva S.A. Ordinary shares, nominal value 0.01 Euro per share on 31 Dec 2025.
Change
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 16:17.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 3.5% | 6,783,269 | 0 | 6,783,269 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 3.5% | 6,783,269 | 0 | 6,783,269 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 3.5% | 6,783,269 | 0 | 6,783,269 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |
CIK / CUSIP context first